Skip to main content

Table 2 Characteristics of the study population

From: Severe tooth wear in Prader-Willi syndrome. A case–control study

 

PWS group (n = 49)

Control group (n = 49)

Age range (years)

6.5-40.9

6.1-42.5

Mean age ± s.d.

20.4 ± 9.5

20.8 ± 10.1

Number of individuals

n

n

Age group 6-18 years

23

23

Age group 19-40 years

26

26

Males/females

25/24

25/24

Supplementary diseases

  

Diabetes

3

0

Epilepsy

3

0

Heart disease

1

0

Daytime sleepiness or

Sleep apnea

20

0

BMI

  

Normal weight

14

49

Overweight

17

0

Obese

18

0

Medication

  

Growth hormone (GH) a

42

0

  1. BMI criteria were age- and gender adjusted for individuals 6-18 years according to International Obesity Task Force (IONT) (37).
  2. aDuration of GH treatment ranged between 6 and 192 months. Mean duration was 72 months.